echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Gen predicts that the next generation sequencing market will reach 4.9 billion US dollars in 2020

    Gen predicts that the next generation sequencing market will reach 4.9 billion US dollars in 2020

    • Last Update: 2014-11-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: biological exploration November 27, 2014 source: iq4i Research & Consulting sequencing technology has experienced a long time, and the next generation sequencing (NGS) has completely changed the way of human genome sequencing Experts predict that in the next few years, the cost of human genome sequencing will be $1000, and the results will be available in 1-2 days Since the first human genome was sequenced (it took 10 years, US $3 billion), the cost and time of sequencing has been greatly reduced The development of NGS has opened a new window for clinical diagnosis Iq4i Research & Consultancy analysis shows that in 2020, the global ngs market will reach US $4.892 billion, with a compound annual growth rate of 20.7% Iq41's report provides a large amount of analysis of market revenue and the operation of NGS samples through a variety of technologies, platforms, end users / laboratories The cost reduction and analysis speed improvement of NGS technology greatly improve its application in clinical field Such a good growth trend also stems from the growth of personalized medicine, the increase of medical expenditure and the transformation from microarray to ngs However, the prospect of NGS is not entirely optimistic The problems it faces include standardization and accuracy of NGS procedures, complexity of data storage and analysis, lack of skilled operators, subsidies and funds for its infrastructure In the global ngs market, instruments and consumables account for the largest proportion, accounting for almost half of the market share in 2013 The fastest growing segment is services, with a CAGR of more than 20% The global ngs market is divided into targeted re sequencing, whole exome sequencing, RNA sequencing, whole genome sequencing, chip sequencing, de novo sequencing and methylation sequencing Among these classifications, targeted re sequencing accounts for the largest market share, and the fastest growing is genome-wide sequencing (with a CAGR of more than 25%) With the emergence of more and more diseases based on ngs detection and platform, targeted re sequencing and whole genome sequencing technology will have the most promising future According to iq4i, academic researchers are the main end users of ngs, accounting for about 60% of the market share Hospitals and clinics have a high CAGR and are expected to have a market share of more than 40% by 2020 In addition, in the clinical field, with the growth of demand and application, the market share is expected to reach about 25% by 2020 According to the classification of application types, the ngs market is divided into tumor, genetic screening, infectious diseases, drug and biomarker discovery, molecular epidemiology, agriculture, etc In all of these applications, tumor detection has the largest market share (over 35%) in revenue and sample size By region, North America has the largest share of the global ngs market, reaching $571 million in 2013; the Asia Pacific region has the highest compound annual growth rate, and will become the fastest growing region in the future At present, the companies participating in the ngs market mainly include Illumina, Thermo Fisher, Hoffmann La Roche, Pacific Biosciences, Agilent Technologies, BGI, Qiagen, biomatters and genomic software Among them, Illumina is the leader of NGS market, followed by Thermo Fisher Scientific and Hoffmann La Roche, which have more than 90% market share Next generation sequencing market expands
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.